DHRM [Dehaier Medical Systems] 424B5:
[]
[Ever-Glory Received a Warning Letter from NYSE Regulations Regarding Failure to Obtain Shareholders Approval on Issuance of Certain Compensation Shares NANJING, China, February 21, 2014 /PRNewswire/ -- Ever-Glory International Group, Inc. (the "Company" or "Ever-Glory") (NYSE MKT: EVK), a leading apparel supply chain manager and retailer based in China, today announced that, on February 14, 2014, it received a warning] [FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): February 21, 2014 (February 14, 2014) EVER-GLORY INTERNATIONAL GROUP, INC. Florida 000-28806 65-0420146 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China (8625) 5209-6889 o ¨ ¨ ¨]
[DEHAIER MEDICAL SYSTEMS LIMITED Issuance Date Date of Issuance: February 21, 2014 (“ Company ____________________ Holder Buyers Securities Purchase Agreement ) (the “ Registration Statement ” Dehaier Medical Systems Limited, a British Virgin Islands company (the “ 1. Mechanics of Exercise Exercise Date Exercise Notice Aggregate Exercise Price st Transfer Agent rd DTC (a) Exercise Price Exercise Price (b) Company’s] [KAUFMAN CANOLES attorneys at law Kaufman & Canoles, P.C. Two James Center, 14 Floor 1021 E. Cary St. Richmond, VA 23219 T (804) 771.5700 F (804) 771.5777 kaufCAN.com February 21, 2014 Dehaier Medical Solutions Limited Room 501, Jiuzhou Plaza, 83 Fuxing Road Haidian District, Beijing 100856 People’s Republic of China Re: Dehaier Medical Solutions Limited Dear Sirs: In connection with] [FORM OF STOCK PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers This RECITALS A. Registration Statement 1933 Act SEC B. Common Shares Registered Shares Each Buyer wishes to purchase, and the Company wishes to sell, upon the terms stated in this Agreement, (i) the aggregate number of common shares, $0.002731 par value per share, of the Company (the “] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement Form S-3 (File No. 333-178268) of Dehaier Medical Systems Limited and Affiliate of our report dated March 18, 2013 with respect to the consolidated financial statements of Dehaier Medical Systems Limited and Affiliate included in the Annual Report (Form 10-K) for the] [BEIJING, February 21, 2014 - Dehaier Medical Systems Ltd. The completion of the offering will occur on or before February 26, 2014. FT Global Capital, Inc. served as the exclusive placement agent for the offering. Copies of the prospectus supplement and accompanying base prospectus relating to this offering may be obtained at the SEC's website at http://www.sec.gov or directly from] []
[DEHAIER MEDICAL SYSTEMS LIMITED Issuance Date Date of Issuance: February 21, 2014 (“ Company ____________________ Holder Buyers Securities Purchase Agreement ) (the “ Registration Statement ” Dehaier Medical Systems Limited, a British Virgin Islands company (the “ 1. Mechanics of Exercise Exercise Date Exercise Notice Aggregate Exercise Price st Transfer Agent rd DTC (a) Exercise Price Exercise Price (b) Company’s] [KAUFMAN CANOLES attorneys at law Kaufman & Canoles, P.C. Two James Center, 14 Floor 1021 E. Cary St. Richmond, VA 23219 T (804) 771.5700 F (804) 771.5777 kaufCAN.com February 21, 2014 Dehaier Medical Solutions Limited Room 501, Jiuzhou Plaza, 83 Fuxing Road Haidian District, Beijing 100856 People’s Republic of China Re: Dehaier Medical Solutions Limited Dear Sirs: In connection with] [FORM OF STOCK PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers This RECITALS A. Registration Statement 1933 Act SEC B. Common Shares Registered Shares Each Buyer wishes to purchase, and the Company wishes to sell, upon the terms stated in this Agreement, (i) the aggregate number of common shares, $0.002731 par value per share, of the Company (the “] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement Form S-3 (File No. 333-178268) of Dehaier Medical Systems Limited and Affiliate of our report dated March 18, 2013 with respect to the consolidated financial statements of Dehaier Medical Systems Limited and Affiliate included in the Annual Report (Form 10-K) for the] [BEIJING, February 21, 2014 - Dehaier Medical Systems Ltd. The completion of the offering will occur on or before February 26, 2014. FT Global Capital, Inc. served as the exclusive placement agent for the offering. Copies of the prospectus supplement and accompanying base prospectus relating to this offering may be obtained at the SEC's website at http://www.sec.gov or directly from] []
[DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE INDEX TO FINANCIAL STATEMENTS UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS PAGE Condensed Consolidated Interim Balance Sheets as of June 30, 2013 and December 31, 2012 F-2 Condensed Consolidated Interim Statements of Income and Comprehensive Income for the Six Months Ended June 30, 2013 and 2012 F-3 Consolidated Interim Statements of Cash Flows for the] [Dehaier Medical Announces 2013 First Half Year Financial Results BEIJING – August 26, 2013 — Dehaier Medical Systems Ltd. (Nasdaq: DHRM) Mr. Ping Chen, Chief Executive Officer of Dehaier Medical, stated, "We are pleased to have expanded into China’s burgeoning sleep respiratory market by entering into a strategic agreement with an Israeli medical signal processing company. As WideMed’s exclusive partner] []
[Origin Agritech Limited Reports Unaudited First Quarter Financial Results Origin Agritech Limited (NASDAQ GS: SEED) (“Origin”, or the “Company”) BEIJING--/PRNewswire/--February, 2014-- FINANCIAL RESULTS OVERVIEW During the first quarter of fiscal year 2014, the Company generated revenues of RMB 20.4 million (US$3.3 million) compared with RMB 22.7 million in the three months ended December 31, 2012. The revenues this quarter were] []
[SUBJECT TO COMPLETION, DATED FEBRUARY , 2014 PRELIMINARY PROSPECTUS American Depositary Shares China Distance Education Holdings Limited Representing Ordinary Shares We are offering American depositary shares, or ADSs, and the selling shareholders identified in this prospectus are offering an additional ADSs. Each ADS represents four ordinary shares, par value US$0.0001 per ordinary share. We will not receive any proceeds from] [21 February, 2014 China Distance Education Holdings Limited 18th Floor, Xueyuan International Tower 1 Zhichun Road, Haidian District Beijing 100083 Peoples Republic of China DIRECT LINE: E-MAIL OUR REF: YOUR REF: 852 2842 9531 Anna.Chong@conyersdill.com AC/al/#5279482 (M#879152) Dear Sirs, China Distance Education Holdings Limited (the Company) F-3, Commission Registration Statement Securities Act Ordinary Shares We have acted as special legal] [February 21, 2014 China Distance Education Holdings Limited 18th Floor, Xueyuan International Tower 1 Zhichun Road, Haidian District Beijing 100083, Peoples Republic of China Re: American Depositary Shares (the ADSs), each representing four ordinary shares of China Distance Education Holdings Limited (the Company) Ladies and Gentlemen: Respectfully submitted, EX-8.1 3 d678659dex81.htm EX-8.1] [34/F, Tower 3, China Central Place, 77 Jianguo Road, Beijing 100025, China Telephone: (86-10) 5809-1000 Facsimile: (86-10) 5809-1100 February 21, 2014 To: China Distance Education Holdings Limited 18th Floor, Xueyuan International Tower 1 Zhichun Road. Haidian District Beijing 100083, China Ladies and Gentlemen, In rendering this opinion, we have examined the originals, or copies certified or otherwise identified to our] [Consent Of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated December 27, 2013, relating to the consolidated financial statements of China Distance Education Holdings Limited, its subsidiaries, its variable interest entity and the subsidiaries of its variable interest entity (collectively, the Group) and the financial]
[Origin Agritech Limited Reports Unaudited First Quarter Financial Results Origin Agritech Limited (NASDAQ GS: SEED) (“Origin”, or the “Company”) BEIJING--/PRNewswire/--February, 2014-- FINANCIAL RESULTS OVERVIEW During the first quarter of fiscal year 2014, the Company generated revenues of RMB 20.4 million (US$3.3 million) compared with RMB 22.7 million in the three months ended December 31, 2012. The revenues this quarter were] []